Knight Therapeutics (KHTRF)

Knight Therapeutics (KHTRF) Financial Statements


Knight Therapeutics Financial Overview

Knight Therapeutics's market cap is currently ―. The company's EPS TTM is $-0.045; its P/E ratio is -84.44; Knight Therapeutics is scheduled to report earnings on March 21, 2024, and the estimated EPS forecast is $0.00. See an overview of income statement, balance sheet, and cash flow financials.
Jun 23Mar 23Dec 22Sep 22Jun 22
Income Statement-
Total RevenueC$ 89.91MC$ 82.60MC$ 81.66MC$ 72.28MC$ 75.82M
Gross ProfitC$ 37.49MC$ 40.76MC$ 36.89MC$ 30.40MC$ 38.30M
EBITC$ 3.22MC$ -2.15MC$ -25.11MC$ 2.33MC$ 2.35M
EBITDAC$ 15.37MC$ 10.93M-C$ 17.60MC$ 16.13M
Net Income Common StockholdersC$ 1.84MC$ -3.94MC$ -15.19MC$ 1.59MC$ 2.52M
Balance Sheet-
Cash, Cash Equivalents and Short-Term InvestmentsC$ 130.50MC$ 145.31MC$ 157.50MC$ 162.31MC$ 149.93M
Total AssetsC$ 1.01BC$ 1.04BC$ 1.05BC$ 1.04BC$ 1.00B
Total DebtC$ 79.20MC$ 82.64MC$ 77.70MC$ 39.06MC$ 38.21M
Net DebtC$ -51.30MC$ -62.67MC$ -79.81MC$ -123.25MC$ -111.72M
Total LiabilitiesC$ 206.54MC$ 225.91MC$ 228.98MC$ 180.83MC$ 171.44M
Stockholders EquityC$ 807.20MC$ 818.87MC$ 825.86MC$ 854.52MC$ 829.69M
Cash Flow-
Free Cash FlowC$ -1.64MC$ -4.08MC$ 2.21MC$ 10.69MC$ -6.72M
Operating Cash FlowC$ -1.49MC$ 3.71MC$ 8.87MC$ 11.33MC$ 11.52M
Investing Cash FlowC$ 4.20MC$ -8.71MC$ -65.02MC$ -3.30MC$ -15.58M
Financing Cash FlowC$ -22.09MC$ -11.27MC$ 29.86MC$ -5.08MC$ -16.20M
Currency in CAD

Knight Therapeutics Earnings and Revenue History

Knight Therapeutics Debt to Assets

Knight Therapeutics Cash Flow

Knight Therapeutics Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis